ROME (Reuters) – Italy’s unemployment rate rose slightly to 7.9% in January from an unrevised 7.8% the month before, national statistics bureau ISTAT said on Thursday. A Reuters survey of analysts had forecast a jobless rate of 7.8%. In January the youth unemployment rate, measuring job-seekers between 15 and 24 years old, increased to 22.9% …
Italy Jan jobless rate edges up to 7.9%, with 35,000 jobs created Read More »
(Reuters) – UK’s FTSE 100 opened lower on Thursday as ex-dividend trading impacted shares of HSBC, although upbeat earnings from Ireland’s CRH and jets and auto parts supplier Melrose helped cap losses. The blue-chip FTSE 100 lost 0.3% by 0821 GMT, while the domestically-focused FTSE 250 midcap index fell 0.3%. Shares of HSBC fell 3.5% …
FTSE 100 opens lower as ex-dividend trading weighs on HSBC Read More »
FRANKFURT (Reuters) – German biotech firm Morphosys said it would stop its work on drug candidates that have not yet been tested on humans after its 2023 revenue prospects worsened. In a statement on Thursday, Morphosys added it would reduce its workforce at the company’s headquarters in Planegg, Germany, by approximately 17% as a result …
Morphosys to slash early drug research programmes to preserve cash Read More »
LONDON (Reuters) – Britain’s Nationwide Building Society has restricted customers’ ability to buy cryptocurrencies, the lender said in an email to its members today. Nationwide said it will not allow payments to crypto exchanges using credit cards and will limit adult current accounts to 5,000 pounds ($5,995.00) per day of purchases. The building society said …
Britain’s Nationwide curbs cryptocurrency purchases by customers Read More »
By Mateusz Rabiega GDANSK (Reuters) -Polish bank Pekao reported a fourth-quarter profit on Thursday that beat estimates, but some analysts signalled that the quality of the beat was not impressive, sending the company’s shares down 2%. For the quarter the bank reported a net profit of 886.1 million zlotys ($201.88 million), compared with estimates of …
Poland’s Pekao falls even as fourth-quarter profit beats expectations Read More »
By Philip Blenkinsop BRUSSELS (Reuters) -Anheuser-Busch InBev, the world’s largest brewer, expanded its profit by slightly more than expected in the fourth quarter as higher prices more than compensated for an overall decline in beer sales. The maker of Budweiser, Corona and Stella Artois said on Thursday that its drinks volumes fell globally by 0.6% …
By Valentina Za MILAN (Reuters) -UniCredit will ask shareholders to approve a new pay structure for Chief Executive Andrea Orcel which offers a 30% rise if the Italian bank beats a wide set of targets this year, a document showed on Wednesday. Orcel’s current pay package of up to 7.5 million euros ($8 million) a …
UniCredit plans 30% CEO pay hike linked to beating goals Read More »
(Reuters) -Purplebricks Group said on Wednesday its strategic review would include a formal sale process, as Britain’s biggest online-only estate agency attempts to turn its fortune around. Purplebricks, which has a market capitalisation of 23.2 million pounds ($28 million), said since its strategic review announcement last month it has received interest from several parties that …
UK’s Purplebricks weighs sale in strategic review Read More »
(Reuters) – Australian investment bank Macquarie Group Ltd is at the early stages of exploring a takeover bid of over 5 billion pounds ($6.00 billion) for British money manager M&G, Sky News reported on Wednesday citing sources. Macquarie is yet to make an approach to M&G’s board, according to the report. The valuation is unclear …
Australia’s Macquarie explores $6 billion deal for Britain’s M&G, Sky News reports Read More »
By Natalie Grover and Bhanvi Satija (Reuters) – Novavax Inc’s shares plunged to a three-year low on Wednesday, a day after the COVID-19 vaccine maker raised doubts about its ability to remain in business. The stock fell as much as 28.3% to $6.64 as of 1:30 p.m. ET (1830 GMT), while its Frankfurt-listed shares slumped …
Novavax sinks on concerns about COVID vaccine maker’s prospects Read More »
